• Betadine® - Iodine-based antiseptic for treatment and prevention of infections in the skin and mucous membranes. Betadine® is the market leader in several European countries.


  • Novopulmon® is an anti-inflammatory corticosteroid (budesonide) with the Novolizer® device for treatment of asthma and COPD .

  • Astepro® is a novel intranasal antihistamine for the treatment for allergic rhinitis.  It has been launched in the USA and it’s in registration phase in Europe.


  • Tambocor® is an antiarrhythmic drug and the market leader in several European countries.


  • EpiPen®  is used for emergency treatment of severe allergic reactions (anaphylaxis) that can occur rapidly and be life-threatening.

  •  


    SB12®  - Controlled breath for 12 hours. SB12 is an oral care agent that neutralizes the substances that causes bad breath.

Meda in brief

Meda is an international specialty pharma company with own operations in 50 countries. Meda has approximately 1700 employees in sales and marketing, and sales that exceeded SEK 11 billion in 2010. We are now the 50th largest pharmaceutical company in the world with products sold in more than 120 countries.